0001824293-23-000152.txt : 20230814 0001824293-23-000152.hdr.sgml : 20230814 20230814160620 ACCESSION NUMBER: 0001824293-23-000152 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230810 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baker David Charles CENTRAL INDEX KEY: 0001844060 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40034 FILM NUMBER: 231169874 MAIL ADDRESS: STREET 1: 100 N. 18TH STREET STREET 2: SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GRI BIO, Inc. CENTRAL INDEX KEY: 0001824293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824369909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 208 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (619) 400-1171 MAIL ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 208 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Vallon Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20200910 4 1 wk-form4_1692043540.xml FORM 4 X0508 4 2023-08-10 0 0001824293 GRI BIO, Inc. GRI 0001844060 Baker David Charles C/O GRI BIO, INC. 2223 AVENIDA DE LA PLAYA, SUITE 208 LA JOLLA CA 92037 1 0 0 0 0 Stock Option (Right to Buy) 2.90 2023-08-10 4 A 0 34483 2.90 A 2033-08-10 Common Stock 34483 34483 D Vests as to 1/12th of the underlying shares of common stock on the date of grant, then in 11 equal quarterly installments such that the stock option is fully vested on the third annual anniversary of the date of grant. /s/ Leanne Kelly, Attorney-in-Fact 2023-08-14